T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
about
T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agentsIdentification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65).The role of environmental factors in insulin-dependent diabetes mellitus: an unresolved issue.ZnT8-Specific CD4+ T cells display distinct cytokine expression profiles between type 1 diabetes patients and healthy adultsCytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylaseThe role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.The role of immunomodulation therapy in autoimmune diabetesGAD-alum (Diamyd)--a new concept for preservation of residual insulin secretion.T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes.Molecular mimicry and the pathogenesis of insulin-dependent diabetes mellitus: still just an attractive hypothesis.Evidence from twins for acquired cellular immune hyperactivity in type 1 diabetes.Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR.Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.Cytokine profile in children during the first 3 months after the diagnosis of type 1 diabetes.Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies.
P2860
Q27485358-E276528B-1476-4860-A7DB-A177E2513CEDQ30454241-8C69C605-1378-46EA-9898-0D9C9CBDDF1FQ33741214-A16A4501-01C5-4F91-B084-D8CB9010D5F1Q34580119-748F1206-C4A3-4C30-B839-0396A524DD6BQ35049679-6AABC30A-102D-48D8-9660-2790D0403646Q35103993-DA3ED30A-063E-4561-B97E-356096C7B6BCQ36755911-62646B8C-4940-4ABB-8D2D-7D64A049C982Q37408019-A454A322-EF94-4233-81E5-B0ACA7FE787FQ37709361-E9291483-8A9F-451A-A7A5-40DAC8B229CAQ40942312-7C11326D-8DAD-4F76-B7B5-1355D82408EBQ41695556-DA5A5C0B-C46C-4319-B8CA-C5565705C1C6Q42524435-2A04D382-CC64-4451-8702-814272A74CE7Q43856153-E3E73154-014B-47A5-A21D-2A73AF3A6265Q47107151-15B828BD-DB17-4020-8607-D09FA3E11B87Q47614059-E83D4E94-1CD2-4052-AD52-150956ABFB46Q48726404-AD16719C-1730-46AD-8827-843700ECE152
P2860
T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
T-cell reactivity to GAD65 pep ...... patients and control subjects.
@en
T-cell reactivity to GAD65 pep ...... patients and control subjects.
@nl
type
label
T-cell reactivity to GAD65 pep ...... patients and control subjects.
@en
T-cell reactivity to GAD65 pep ...... patients and control subjects.
@nl
prefLabel
T-cell reactivity to GAD65 pep ...... patients and control subjects.
@en
T-cell reactivity to GAD65 pep ...... patients and control subjects.
@nl
P2093
P356
P1433
P1476
T-cell reactivity to GAD65 pep ...... patients and control subjects.
@en
P2093
P2888
P304
P356
10.1007/S001250050683
P577
1997-03-01T00:00:00Z
P5875
P6179
1004714761